Life Care Capital, the first Italian Special Purpose Acquisition Company (Spac) focused on healthcare and pharma sectors, closed its fundraising a few days ago cashing in committments from investors well over the 100 million euros minimum target. Rumors are that the orders book was around 140 million euros, near the 150 million euros maximum target (see here a previous post by BeBeez). Today is expected an official statement about the fundraising and the company is expected to list at the Aim Italia market next Wed March 7th,  Il Sole 24 Ore wrote.
Promoters of this Spac are: Alessandra Gavirati, till now a partner in private equity firm Synergo sgr and formerly in private equity firms BS Private Equity and Sopaf (Mrs. Gavirati will be ceo); Carlo Castellano, founder of pharma company Esaote, who will be chairman; Italian financier Jody Vender, fouder of Sopaf;  Luigi Sala, a co-founder of BS Private Equity and former chairman of Italian private equity firm Charme; and Alessandro Piga, co-founder of investment company Techwald holding, focused on medtech. Among independent directors seats Alberto Dalmasso, founder of Italian fintech company Satispay.
Bookrunner is Equita sim. The Spac will invest in minorities or in a controlling stake of italian companies with an equity value in a range of 150-500 million euros active in the sector of healthcare, diagnostics, pharma, biotech, blood derivatives or packaging, logistics and automation in the same sectors.
